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Abstract
Introduction: Autonomic disturbances in tetanus are traditionally associated with adrenergic
variations and/or cardiac dysfunction, based on case report data. The objective of this study was to
measure catecholamines, (TNF)-α and troponin T relative to and left ventricular ejection fraction
(LVEF) in patients with severe tetanus.
Methods: This prospective study was carried out at two general Intensive Care Units and included
21 patients consecutively admitted with severe tetanus. Catecholamines (dopamine,
norepinephrine, epinephrine and total catecholamines), tumor necrosis factor (TNF)-α and LVEF
were assessed during the first week of autonomic instability and following tetanus recovery.
Troponin T was measured during autonomic instability only.
Results: Mean age of patients was 46 ± 17 years, median Acute Physiology and Chronic Health
Evaluation II (APACHE II) score was 8 (range 1–23). All patients had both blood pressure and heart
rate instability. Two patients were recuperated from cardiac arrest. Intensive Care Unit mortality
was 14% (3 cases). No increase in total catecholamines or in TNF-α levels was observed during
autonomic instability or in the recovery period. Six patients had troponin T >0.01 ng/ml and six had
>0.1 ng/ml. Mean LVEF was similar during autonomic instability and after tetanus recovery, 67 ± 7%
and 65 ± 7%, respectively. Troponin T levels correlated with pressoric instability during autonomic
instability.
Conclusion: Our study demonstrated that in patients with severe tetanus no significant increased
levels of catecholamines or TNF-α or evidence of cardiac systolic dysfunction was observed either
during autonomic instability or in the recovery period. Elevated values of troponin T detected
during autonomic instability were not associated with left ventricular dysfunction. Our data do not
support the hypothesis that autonomic disturbances in tetanus are associated with adrenergic
variations or cardiac dysfunction.
Introduction
Autonomic dysfunction, sudden death and complications
of prolonged critical disease, such as nosocomial infec-
tions, thromboembolism and gastrointestinal bleeding
Published: 17 February 2006
Journal of Negative Results in BioMedicine2006, 5:2 doi:10.1186/1477-5751-5-2
Received: 04 January 2006
Accepted: 17 February 2006
This article is available from: http://www.jnrbm.com/content/5/1/2
© 2006Brauner and Clausell; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Negative Results in BioMedicine 2006, 5:2 http://www.jnrbm.com/content/5/1/2
Page 2 of 7
(page number not for citation purposes)
are main causes of death in tetanus [1]. In a previous study
we showed that autonomic instability occurred in 100%
of patients with tetanus, and that 35% of deaths were
timely associated with the symptomatic period, cardiac
arrest and hypotension, and inversely associated with the
duration of the onset period [2].
Autonomic instability as defined by Kerr et al., is a charac-
teristic syndrome whose features include sustained but
labile hypertension and tachycardia, irregularities of car-
diac rhythm, peripheral vascular constriction, profuse
sweating, pyrexia, increased carbon dioxide output,
increased urinary catecholamine excretion, and, in some
cases, the development of hypotension [3]. Severe hyper-
tension and tachycardia may alternate with profound
hypotension and bradycardia, suggesting intense sympa-
thetic activity [3,4]. Accordingly, both increased urinary
and plasmatic levels of catecholamines have been
described in this setting [3,5]. Other authors, however,
found normal excretion and plasma catecholamine levels
in patients with tetanus [5,6], indicating that an associa-
tion between elevated catecholamine levels and auto-
nomic instability remains to be further documented.
Bradycardia is also occasionally noticed, which suggests
parasympathetic system or basal nucleus dysfunction,
leading to excessive vagal activity [7,8].
Prolonged stimulation of the sympathetic nervous system
or the continuous release of catecholamines may cause
vascular and myocardial damage [9,10]. However, histo-
logic evidence of myocardial necrosis in tetanus was dem-
onstrated in few cases [11]. It was suggested that either a
sudden loss of catecholamine stimulation or myocardial
damage caused by the direct action of the tetanus toxin,
could be involved in cardiac dysfunction described in tet-
anus [12,13]. However, an invasive hemodynamic study
involving 27 patients with severe tetanus showed a hyper-
dynamic profile rather than depressed cardiac function
[14]. Since it is well known that myocardial damage
caused by catecholamines can induce synthesis of
cytokines by myocytes [15,16], cytokines, specifically
those with known cardiodepressant properties such as
TNF-α, could be an alternative mechanism involved in
cardiac dysfunction, in the setting of tetanus.
The objective of the present study was to evaluate the tem-
poral behavior of catecholamines and of TNF-α relative to
left ventricular ejection fraction obtained by two-dimen-
sional transthoracic echocardiography at two time points:
during autonomic instability and after recovery from teta-
nus. Levels of the troponin T were used to identify poten-
tial myocardial damage in the period of autonomic
instability. In this report our data failed to indicate associ-
ations between adrenergic and cytokine activation with
changes in cardiac performance in patients with tetanus.
Methods
Study population
This cohort study included all patients with a diagnosis of
severe tetanus characterized by marked rigidity, frequent
generalized spasms, dysphagia, respiratory compromise
or apnea according to the modified Abblett's scale,
[17,18] consecutively admitted to the ICU of two general
hospitals (Hospital Nossa Senhora da Conceição and
Hospital de Clínicas de Porto Alegre, Brazil). Data were
prospectively collected without interference in manage-
ment. Patients with other potential causes of hemody-
namic instability such as septic shock were excluded from
the study. The study was approved by the Ethics Commit-
tees from both hospitals. Patients' legal representatives
signed an informed consent document prior to enrol-
ment. A portion of this population was part of the entire
cohort of our previous study reporting demographics and
prognosis of patients with tetanus [2].
The main variables of the study were: plasma catecho-
lamines, TNF-α, troponin T levels and transthoracic
echocardiographic-based LVEF. These variables were
assessed both during the autonomic instability and after
recovery from tetanus, with the exception of troponin T,
only measured during autonomic instability. The follow-
ing variables were also recorded: age, sex, APACHE II score
in the first 24 hrs of ICU admission, temporal develop-
ment of symptoms, periods of the disease (incubation
period, onset period, symptomatic period), clinical char-
acteristics, clinical and infectious complications and elec-
trocardiogram (EKG).
Evaluation of autonomic profile, catecholamine levels and 
TNF-α
Autonomic instability was characterized by the presence
of blood pressure and heart rate lability, arrhythmias and/
or cardio respiratory arrest recorded by continuous nonin-
vasive monitoring (monitor 66S, Hewlett-Packard, USA),
as reported previously [2]. Variation from minimum to
maximum (delta) of blood pressure and of heart rate was
recorded in both periods.
At the end of the first week of autonomic instability and
after recovery from tetanus, 10 ml blood sample was col-
lected into an EDTA-containing tube and kept under
refrigeration. Samples were immediately centrifuged at
5°C, plasma was placed in 1.5 ml Eppendorf tubes and
stored at -80°C for later measurement of plasma catecho-
lamines and TNF-α levels. Catecholamine levels (epine-
phrine, norepinephrine, dopamine and total
catecholamines) were measured at CRIESP laboratory
(São Paulo, Brazil) using high performance liquid chro-
matography (HPLC). Commercially available Elisa assays
were used to measure TNF-α plasma levels using duplicate
samples to minimize inter-assay variability. Lower detec-Journal of Negative Results in BioMedicine 2006, 5:2 http://www.jnrbm.com/content/5/1/2
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tion limits of the assay were typically less than 4.4 pg/ml
(R & D Systems, Minneapolis, MN, USA).
Troponin T levels during autonomic instability
During autonomic instability, blood samples collected
were also used for measurement of plasma troponin T lev-
els using a sandwich electrochemiluminescence immu-
noassay (ECLIA), Elecsys Troponin T STAT (Roche,
Germany). Detection band ranges from 0.01 ng/ml to 25
ng/ml in this assay. In 99% of healthy volunteers, the cut-
off point was lower than 0.01 ng/ml, and the cutoff point
for myocardial infarction was 0.1 ng/ml [19-21].
Transthoracic echocardiography functional evaluation
Two-dimensional color Doppler transthoracic echocardi-
ography was performed at the two collection time points
(autonomic instability and after recovery period) to meas-
ure LVEF by the M-mode (Teicholtz method), in accord-
ance to the recommendations of the American Society of
Echocardiography. Whenever possible, hemodynamic
status of patients were kept at the best possible care
according to the ICU protocols in order to avoid con-
founding load variables interfering with ejection fraction
measurements. Simultaneously to echocardiogram, blood
pressure and heart rate were recorded as well as blood
sampling to measure biological variables. Additional
echocardiography-based cardiac findings were also
recorded. Data were recorded and later re-evaluated by
another blinded echocardiographist.
Statistical analysis
Continuous variables are described as means and stand-
ard deviation or medians and range; categorical variables
are described by frequency tables and proportions. Magni-
tude of variation from minimum to maximum values of
variables (heart rate and blood pressure) were calculated
and expressed as delta values. Discrimination between
parametric and non-parametric variables was performed
using histograms and the Kolmogorov-Smirnov test. Stu-
dent t test was used to compare continuous and normally
distributed variables; Mann Whitney test was used for
asymmetric continuous variables, and the chi-square test
for categorical variables. Paired samples t tests and Wil-
coxon test were used to compare continuous variables
during and after autonomic instability. Pearson and
Spearman tests were used to evaluate correlation between
variables. Significance level was established at p < 0.05 for
all comparisons.
Results
Clinical characteristics
We evaluated 21 patients with severe tetanus, 18 (84%)
males, mean age 46 ± 17 years, with median APACHE II
score of 8 (range – 1–23). Incubation period was 7.0 ± 4
days, onset period was 3 ± 3 days and symptomatic period
was 40 ± 10 days. All patients were mechanically venti-
lated (mean 41 ± 12 days) and the length of stay in the
ICU was 45 ± 13 days. ICU mortality rate was 14% (three
patients), thus 18 patients underwent after recovery
Table 1: Clinical and laboratory findings during autonomic instability at time of collection.
Patient Age APACHE MBP HR CREAT TROP T Infection Germ AB
MAPRR 20 6 145 129 0.8 <0.01 Blood S. aureus vancomycin
VPO 48 3 110 127 1.1 0.012 - - penicillin
MSR 54 4 49 109 0.5 0.07 respiratory central line S. aureus vancomycin
JP 50 8 84 124 0.6 <0.01 respiratory ? cefuroxime
JRS 74 10 78.6 122 1.4 0.306 - - penicillin
ESB 19 6 62 81 0.8 <0.01 - - penicillin
CEO 53 8 78.6 92 0.5 0.135 respiratory S. aureus vancomycin
RAB 57 6 69 74 1.1 0.015 - - penicillin
JOR 57 15 100.6 129 1.0 0.028 osteomyelitis - ofloxa, metro
JBS 48 10 90 98 0.7 0.02 - - penicillin
GS 36 11 67 96 1.0 0.045 respiratory S. aureus vancomycin
SBD 33 15 88 71 0.8 0.105 respiratory ? cefipime
LCCM 48 4 93.6 62 0.6 <0.01 respiratory P. mirabilis ampisulbact
MJO 29 1 87 88 0.7 <0.01 - - penicillin
JCWV 20 5 290 133 0.7 <0.01 respiratory ? ampisulbact
IMR 60 23 66 86 0.7 <0.01 respiratory P. aeruginosa ampisulbact
MS 70 11 48.3 78 1.1 0.137 Blood S. aureus vancomycin
ER 44 11 75 81 1.1 0.135 Blood S. epidermitis oxacillin
LSLF 36 10 70 100 1.0 <0.01 - - ampicillin
MLS 82 21 24 92 1.5 0.2135 - - penicillin
JS 44 2 126 75 1.0 <0.01 - - penicillin
Mean (SD) 46.7 (17.2) 9 (5.7) 81.3 (26.7) 97.4 (22.1) 0.9 (0.2) 0.6 (0.08)
SD = standard deviation; MBP = mean blood pressure; HR = heart rate; CREAT = creatinine; TROP T = troponin T; AB = antibiotic (ofloxa = 
ofloxacin; ampisulbact = ampicillin/sulbactam; metro = metronidazole).Journal of Negative Results in BioMedicine 2006, 5:2 http://www.jnrbm.com/content/5/1/2
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assessments. Seven patients had chronic obstructive pul-
monary disease, six had history of alcohol abuse, three
had hypertension, and three had history of coronary
artery disease. Patients received diazepam (mean dose =
33.9 ± 8.0 mg/h), pancuronium (mean dose = 0.8 ± 0.08
mg/kg/h) and morphine (median dose = 3 mg/h; range –
0–20) intravenously, continuously. In addition to drugs
used for sedation, seven patients also received clonidine
0.150 mg/day. All patients received antibiotics – nine for
tetanus only, and 12 for other infections also. The most
frequent clinical and infectious complications were: pul-
monary atelectasis (57%), renal failure (24%), respiratory
infection (90%), urinary infection (81%), and central line
infection (38%). Individual clinical characteristics are
shown in Table 1.
Autonomic profile
All patients had autonomic instability characterized by
blood pressure or heart rate variation, other arrhythmias
or cardiac arrest. During autonomic dysfunction, mean
maximum heart rate was 143 ± 17 bpm and mean mini-
mum heart rate was 59 ± 18 bpm. Ten patients had
marked bradycardia (two had third degree AV block
requiring pacemaker implants), two had recuperated car-
diac arrest and one had atrial fibrillation. Mean blood
pressure during hypertension periods ranged from 109 to
199 mmHg and from 15 to 73 mmHg during hypotension
periods.
Catecholamine levels
Catecholamine concentrations were measured during the
first week of autonomic instability and after recovery from
tetanus. When plasma concentrations in the two periods
were compared, we observed that levels of epinephrine
(195 ± 83 versus 239 ± 105 pg/ml), norepinephrine (218
± 88 versus 261 ± 96 pg/ml), dopamine (198 ± 109 versus
204 ± 111 pg/ml) and total catecholamines (414 ± 138
versus 500 ± 174 pg/ml) tended to be higher after recovery
from tetanus, although within normal limits (Figure 1).
Individual measurements showed levels above normal for
dopamine in 11 patients, epinephrine in three patients,
and norepinephrine in one patient during autonomic
instability.
TNF-α levels
Levels of TNF-α showed similar median plasma concen-
trations in both periods, i.e. 4.5 (range -2.7–6.7) pg/ml
and 4.1 (range -1.2–6.8) pg/ml in autonomic instability
and after tetanus recovery, respectively p > 0.05 (Figure 2).
Plasma levels of < 15.6 pg/ml were considered within nor-
mal expected values, according to the manufacturer.
Troponin T concentrations and electrocardiogram
Analysis of plasma troponin T concentrations during
autonomic instability revealed that nine patients had val-
ues lower than 0.01 ng/ml, and that 12 had values greater
than 0.01 ng/ml. Of these, six patients had troponin T
concentrations greater than 0.1 ng/ml. Patients with
plasma troponin T concentrations greater than 0.01 ng/ml
(n = 12) had greater delta systolic pressure values (142 ±
50 mmHg versus 99 ± 20 mmHg, p = 0.026), greater delta
mean blood pressure values (106 ± 39 mmHg versus 76 ±
20 mmHg, p = 0.056) and were older (54.7 ± 14.7 versus
36.2 ± 15.1 years, p = 0.01) than patients with troponin T
levels < 0.01 pg/ml. Troponin T was inversely associated
with systolic pressure (r = -0.53, p = 0.01) during auto-
nomic instability period.
Levels of different catecholamines (pg/ml) at the two collec- tion time points Figure 1
Levels of different catecholamines (pg/ml) at the two collec-
tion time points. Mean and standard deviation values. DOP = 
dopamine; AD = epinephrine; NE = norepinephrine; TC = 
total catecholamines; AI = autonomic instability; Post-AI = 
after recovery from tetanus.
Box plot graph comparing TNF-α levels (pg/ml) at the two  collection time points Figure 2
Box plot graph comparing TNF-α levels (pg/ml) at the two 
collection time points. Median and percentile values (25th and 
75th). AI = autonomic instability; Post-AI = after recovery 
from tetanus.Journal of Negative Results in BioMedicine 2006, 5:2 http://www.jnrbm.com/content/5/1/2
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EKG findings performed at different time points were sim-
ilar to baseline EKG (including the fact that no new Q
waves were identified), except for arrhythmias.
Transthoracic two-dimensional echocardiography
Transthoracic two-dimensional echocardiography with
Doppler was performed at the bedside during autonomic
instability. In some patients, important variations of
blood pressure occurred during the echocardiograms, but
LVEF values remained within normal limits. The exam
was repeated in the echocardiography laboratory under
optimal conditions, after recovery from tetanus. Mean
ejection fraction measured during autonomic instability
and in the recovery period was 67 ± 7% and 65 ± 7%,
respectively (p = 0.41).
Discussion
In this study in severe tetanus, all patients had autonomic
instability characterized by cardiac arrhythmias, blood
pressure instability, and/or cardiac arrest. However, these
findings were not associated with increase in plasma cate-
cholamine levels or in biological markers of inflamma-
tory response. In spite of an increase in levels of the
myocardial damage marker troponin T in 12 patients, this
was not associated with cardiac dysfunction, as assessed
by LVEF.
Autonomic instability and plasma catecholamines
In our study, plasma catecholamine levels were within
normal ranges during autonomic instability; in fact, mean
levels tended to be higher after recovery from tetanus.
Autonomic instability in tetanus suggests intense sympa-
thetic activity [4]; this has been associated with high cate-
cholamine, mainly norepinephrine, levels [9,10,22].
However, some case reports showed contradictory results,
reporting elevated [3,23] or normal [6] levels of urinary
catecholamine excretion. A case report of one patient,
where catecholamines were measured in a hourly basis,
showed increase in catecholamine levels during hyperten-
sive periods and normal levels when blood pressure was
normal. Urinary levels were normal too [22]. Another
study showed increased levels of catecholamines in three
patients during periods of hypertension, but the patient
who was under curare had near normal catecholamine
levels [5]. Differently from our approach, others have
measured urinary levels of catecholamines, observing
both normal or elevated levels [3,6,23]. From the above
studies, measuring either urinary or plasma levels of cate-
cholamines in patients with tetanus, no definite consen-
sus can be determined as to which is the best approach. As
during autonomic instability, variation of blood pressure
can be very rapid, we chose to measure catecholamines
using HPLC, considered a sensitive detection method, in
only one moment, which could be temporally associated
or not with hypertensive peaks. However, we did not
observe increase in catecholamine levels when blood
pressure values were at their peak
Normal catecholamine concentrations observed during
autonomic instability may also be explained by the phar-
macological treatment and resources available nowadays
in ICUs, which allow the patient to be kept under deep
sedation to control spasms and under adequate mechani-
cal ventilation. Thus, our findings cannot be truly com-
pared to previous reports mentioned above regarding
catecholamine levels [3,22,23], mainly because availabil-
ity of treatment strategies was markedly different. After
recovery from tetanus, without anesthesia and under nor-
mal conditions, plasma catecholamines may have
returned to their usual concentrations; therefore higher
than those from the autonomic instability period. Alter-
natively, other authors postulate that vasomotor disorders
in severe tetanus results from changes in systemic vascular
resistance secondary to the involvement of the central
nervous system [12,13,24]. An alternative would be that
autonomic dysfunction in tetanus may not be mediated
by plasma catecholamines but neurally, and therefore not
reflected by plasma catecholamines levels. In fact, cate-
cholamines activity is complex and involves a multistep
G-proteins, protein kinase C, cAMP and phosphodieste-
rase actions. Coupling between these components
appears to be highly modulable [25]. Interestingly, evalu-
ation of autonomic nervous system function with spectral
analyses of heart rate variability in a case of tetanus,
recently revealed profoundly decreased activity of both
sympathetic and parasympathetic modulation of cardiac
rhythm, but with predominant parasympathetic nervous
system impairment [26].
TNF-α levels
In this study, levels of TNF-α were not above expected nor-
mal limits. To our knowledge, no previous studies
attempted to characterize cytokine profile in patients with
tetanus, which limits our ability to compare ours to find-
ings from others. Our group, as well as others, has shown
that TNF-α levels are increased in the context of sepsis
[27]. In this study some patients had documented infec-
tion although sepsis criteria were difficult to determine
because of autonomic instability. However, patients with
tetanus are not fully comparable to patients with sepsis, as
tetanus is characterized by an intoxication of the central
nervous system by the tetanic toxin, not necessarily an
infectious process related/associated with sepsis. An alter-
native hypothesis was that potentially elevated cytokines
in the setting of tetanus could be related to myocardial
damage caused by excessive and continuous sympathetic
drive [9]. However, in our study no such excessive produc-
tion of catecholamines was found, further restraining pos-
sible sources of increased TNF-α.Journal of Negative Results in BioMedicine 2006, 5:2 http://www.jnrbm.com/content/5/1/2
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Troponin T levels
In our series, most patients had elevated levels of this
marker but no new Q waves were observed in the EKGs
performed afterwards. Few reports in experimental in vitro
models of tetanus have demonstrated increased tradi-
tional cardiac enzymes [28]. This is the first time (to our
knowledge) that troponins are evaluated in the setting of
tetanus; on the other hand, these markers are described to
be elevated even in healthy individuals after extraneous
physical activity [29], probably indicating some degree
muscle damage. Likewise, in our patients it is possible that
some degree of myocyte damage occurred but perhaps not
clinically relevant to produce noticeable Q waves at the
EKG. However, we observed an inverse association of tro-
ponin T and systolic pressure, a positive association with
diastolic pressure and mean blood pressure variations,
suggesting that pressure instability contributed to eleva-
tion of troponin T in these patients. Similarly, findings of
increased troponins in sepsis have also been found to be
associated with duration of hypotension, but not with
areas of necrosis by EKG findings [30]. Therefore, our data
may suggest that as in SIRS events and in sepsis, blood
pressure instability may influence the elevation of tro-
ponin concentrations without myocardial necrosis in tet-
anus.
Left ventricular ejection fraction
In our study, echocardiography evaluation during auto-
nomic instability failed to identify systolic ventricular dys-
function or regional contractility abnormalities. In spite
of the occurrence of variable values of blood pressure dur-
ing echocardiography, practically all patients maintained
normal ejection fraction, indicating a well preserved car-
diac reserve in this setting. These findings were confirmed
by transthoracic echocardiography performed under ideal
conditions after recovery from tetanus. These observa-
tions were compatible with the absence of ischemic or
necrosis areas by EKG, in spite of elevated troponin T lev-
els.
Previous studies of severe tetanus with autonomic insta-
bility suggested the occurrence of myocardial dysfunction
secondary to myocardial necrosis caused by tetanic toxin
and to elevated catecholamine concentrations [4,8,11,31-
33]. A study using invasive hemodynamic assessment
showed a profile compatible with hyperdynamic response
[14]. Although invasive assessment of cardiac function
may not be methodologically comparable to echocardiog-
raphy-based evaluation, our data, nonetheless, indicate
that cardiac function was in fact preserved during auto-
nomic instability, not necessarily reflecting an hyperdy-
namic pattern, since in both autonomic instability and
after tetanus recovery similar/normal values for LVEF were
observed.
Limitations of the study
Only one measurement of catecholamine and TNF-α con-
centrations was performed during the autonomic instabil-
ity period, which may not have coincided with the peak of
release of these substances. However, according to previ-
ous reports available [4,5,22,23] we assumed that signifi-
cant increases in catecholamine levels were present during
the entire autonomic instability period. Serial measure-
ments could have provided different results.
Conclusion
In patients with severe tetanus, during the period of auto-
nomic instability, our data failed to demonstrate the pres-
ence of increased levels of catecholamines or the presence
of cardiac dysfunction. Thus, our data do not support the
hypothesis that autonomic disturbances in tetanus are
secondary to adrenergic variations or cardiac dysfunction.
Additionally, it may be suggested that within-normal lim-
its levels of catecholamines in the autonomic instability
period may be explained by overblurred of the autonomic
system in tetanus.
We speculate that additional mechanisms, perhaps of cen-
tral origin, may play more important roles in the patho-
genesis of autonomic dysfunction in tetanus, and that
levels of catecholamines and cardiac dysfunction contrib-
ute less importantly. Experimental studies are required to
further elucidate cause-effect relationship between these
events in tetanus.
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